InChI=1S/C25H42N2O19/c1-7(30)26-13-9(32)3-25(24(40)41,46-21(13)15(34)10(33)4-28)42-6-12-16(35)18(37)19(38)23(44-12)45-20-11(5-29)43-22(39)14(17(20)36)27-8(2)31/h9-23,28-29,32-39H,3-6H2,1-2H3,(H,26,30)(H,27,31)(H,40,41)/t9-,10+,11+,12+,13+,14+,15+,16-,17+,18-,19+,20+,21+,22+,23-,25+/m0/s1 |
RPSBVJXBTXEJJG-LURNZOHQSA-N |
[H][C@]1(O[C@@](C[C@H](O)[C@H]1NC(C)=O)(OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](NC(C)=O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O)C(O)=O)[C@H](O)[C@H](O)CO |
|
epitope
The biological role played by a material entity when bound by a receptor of the adaptive immune system. Specific site on an antigen to which an antibody binds.
|
|
5-acetamido-3,5-dideoxy-D-glycero-α-D-galacto-non-2-ulopyranonosyl-(2→6)-β-D-galactopyranosyl-(1→4)-2-acetamido-2-deoxy-β-D-glucopyranose
|
(2R,4S,5R,6R)-5-acetamido-2-{[(2R,3R,4S,5R,6S)-6-{[(2R,3S,4R,5R,6R)-5-acetamido-4,6-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy}-3,4,5-trihydroxyoxan-2-yl]methoxy}-4-hydroxy-6-[(1R,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid
|
HMDB
|
(N-acetylneuraminosyl(alpha2-6)lactosamine)
|
HMDB
|
6'-Sialyllactosamine
|
HMDB
|
6-Sialyllactosamine
|
ChemIDplus
|
alpha-N-acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
|
ChEBI
|
alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
|
KEGG COMPOUND
|
alpha-N-Acetylneuraminyl-2,6-beta-D-galactosyl-1,4-N-acetyl-beta-D-glucosamine
|
HMDB
|
alpha-N-Acetylneuraminyl-2,6-beta-delta-galactosyl-1,4-N-acetyl-beta-delta-glucosamine
|
HMDB
|
α-NeuNAc-(2→6)-β-D-Gal-(1→4)-β-D-GlcNAc
|
ChEBI
|
α-NeupNAc-(2→6)-β-D-Galp-(1→4)-β-D-GlcpNAc
|
ChEBI
|
N-Acetylneuraminosyl(alpha2-6)lactosamine
|
ChemIDplus
|
Neu5Aca2-6Galb1-4GlcNAcb
|
ChEBI
|
Neuac-lact
|
ChemIDplus
|
NeuAcalpha2,6Galbeta1,4GlcNAc
|
HMDB
|
Neuacalpha2,6GalNAcbeta1,4GlcNAc
|
ChemIDplus
|
Neuacalpha2-6Galbeta1-4GlcNAcbeta
|
ChemIDplus
|
O-(N-Acetyl-a-neuraminosyl)-(2→6)-O-b-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-b-D-Glucopyranose
|
HMDB
|
O-(N-Acetyl-alpha-neuraminosyl)-(26)-O-beta-D-galactopyranosyl-(1→-4)-2-(acetylamino)-2-deoxy-beta-D-Glucopyranose
|
HMDB
|
O-(N-Acetyl-alpha-neuraminosyl)-(2→6)-O-beta-delta-galactopyranosyl-(1→-4)-2-(acetylamino)-2-deoxy-beta-delta-Glucopyranose
|
HMDB
|
O-5-(acetylamino)-3,5-dideoxy-D-glycero-α-D-galacto-2-nonulopyranonosyl-(2→6)-O-β-D-galactopyranosyl-(1→4)-2-(acetylamino)-2-deoxy-β-D-glucopyranose
|
ChEBI
|
WURCS=2.0/3,3,2/[a2122h-1b_1-5_2*NCC/3=O][a2112h-1b_1-5][Aad21122h-2a_2-6_5*NCC/3=O]/1-2-3/a4-b1_b6-c2
|
GlyTouCan
|
5721087
|
Beilstein Registry Number
|
Beilstein
|
64364-50-7
|
CAS Registry Number
|
ChemIDplus
|